Laml T, Schulz-Lobmeyr I, Obruca A, Huber J C, Hartmann B W
Division of Gynecology, University of Vienna Medical School, Austria.
Gynecol Endocrinol. 2000 Aug;14(4):292-302. doi: 10.3109/09513590009167696.
A search of past and current articles on ovarian physiology and premature ovarian failure (POF) using MEDLINE was performed in order to present an overview of clinical manifestations, necessary laboratory investigations, possible etiologies and treatments for POF. POF is defined as gonadal failure before the age of 40 years. Initially, POF was thought to be permanent, but it is now believed that spontaneous remissions and even pregnancies are possible in affected women. In most cases, the etiology of POF remains elusive, but several rare specific causes have been identified. Although the etiology of POF is heterogenic, the treatment principles are the same. Hormone replacement therapy (HRT) is still the cornerstone of treatment. The only proven method of obtaining a pregnancy in patients with POF is fertilization of a donor oocyte. Cryopreservation of oocytes has worked well in animals but awaits refinement before it can be applied routinely to humans with prodromal POF, or to patients before chemotherapy or irradiation in order to save their oocytes for future fertilization. New alternatives to traditional HRT and methods of fertility preservation are under development, but understanding of the basic pathophysiology of POF is necessary for the development and use of innovative treatments.
为了概述卵巢早衰(POF)的临床表现、必要的实验室检查、可能的病因及治疗方法,我们利用医学文献数据库(MEDLINE)检索了有关卵巢生理学和卵巢早衰的既往及当前文章。卵巢早衰被定义为40岁之前的性腺功能衰竭。最初,人们认为卵巢早衰是永久性的,但现在相信受影响的女性有可能自然缓解甚至怀孕。在大多数情况下,卵巢早衰的病因仍不明确,但已确定了一些罕见的具体病因。尽管卵巢早衰的病因具有异质性,但其治疗原则是相同的。激素替代疗法(HRT)仍然是治疗的基石。在卵巢早衰患者中,唯一经证实的怀孕方法是使用供体卵母细胞进行受精。卵母细胞冷冻保存技术在动物实验中效果良好,但在能够常规应用于卵巢早衰前驱期的人类患者,或应用于化疗或放疗前的患者以保存其卵母细胞用于未来受精之前,仍有待完善。传统激素替代疗法的新替代方法和生育力保存方法正在研发中,但对于创新治疗方法的开发和应用而言,了解卵巢早衰的基本病理生理学是必要的。